PEAK6 Investments’s Outset Medical OM Stock Holding History

PEAK6 Investments’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,062	Closed	-$1.21M	–	5006
2022 Q3	$1.21M	Buy	+5,062	New	+$1.36M	0.01%	2015

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PEAK6 Investments's OM Position: Q4 2022 in Review

PEAK6 Investments sold out of Outset Medical (OM) in Q4 2022, closing a stake of 5,062 shares — an estimated $1.21M sold.

PEAK6 Investments first reported a position in OM in Q3 2022 and held it in 1 quarter. The position peaked at $1.21M in Q3 2022. 151 funds tracked by Wall St. Rank hold OM as of Q4 2022.

PEAK6 Investments reported no remaining Outset Medical position as of Q4 2022 after selling out during the quarter.
PEAK6 Investments sold 5,062 Outset Medical shares in Q4 2022, an estimated $1.21M.
PEAK6 Investments first reported a position in Outset Medical in Q3 2022 and held it in 1 quarter.
PEAK6 Investments's Outset Medical position peaked at $1.21M in Q3 2022.
151 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.